Back to mobile site

Regeneron Pharma (REGN) PT Lowered to $801 at Truist 'To Refresh Risk/Reward'

March 31, 2026 7:04 AM EDT Send to a Friend
(Updated - March 31, 2026 9:41 AM EDT)

Truist Securities analyst Greg Renza lowered the price target on Regeneron ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login